Secondary Pure Red Cell Aplasia in Multiple Myeloma Treated with Lenalidomide
Overview
Authors
Affiliations
Pure red cell aplasia (PRCA) is a rare disorder characterized by marked erythroid hypoplasia with maturation arrest in the bone marrow. Secondary acquired PRCA may be associated with hematologic disorders. A few case reports have described PRCA associated with multiple myeloma (MM). However, the clinical course and mechanism of PRCA associated with MM remain unknown. We herein report two cases of PRCA associated with MM in patients undergoing treatment with lenalidomide.
Alharbi M, Bawek S, Lund I, Glenn S, Green S, Hassan H Ann Hematol. 2025; .
PMID: 39969535 DOI: 10.1007/s00277-025-06218-z.
Hu Q, Liu Y, Yue Q, Zhou S, Jin X, Lin F Nat Commun. 2024; 15(1):10131.
PMID: 39578482 PMC: 11584757. DOI: 10.1038/s41467-024-54571-w.
Jin X, Jiang X, Wang W, Liu S, Han B, Han J Chronic Dis Transl Med. 2023; 9(4):341-344.
PMID: 37915388 PMC: 10617308. DOI: 10.1002/cdt3.81.
Kakubu M, Bikinesi T, Katoto P Oxf Med Case Reports. 2023; 2023(3):omad022.
PMID: 36993835 PMC: 10041944. DOI: 10.1093/omcr/omad022.